Sep 04, 2019 7:00am EDT Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference
Aug 14, 2019 6:15am EDT Sutro Biopharma Reports Second Quarter 2019 Financial Results and Recent Business Highlights and Developments
Jun 15, 2019 6:00am EDT Sutro Biopharma Announces Encouraging Interim Phase 1 Safety Data on a Potential First-in-Class Antibody-Drug Conjugate STRO-001 for the Treatment of B-cell Malignancies at the European Hematology Association Congress
May 16, 2019 9:02am EDT Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress
May 15, 2019 7:00am EDT Sutro Biopharma Reports First Quarter 2019 Financial Results and Recent Business Highlights and Developments
Apr 01, 2019 5:00am EDT Sutro Biopharma Reports Full Year 2018 Financial Results and Recent Business Highlights and Developments
